LEIDOS BIOMEDICAL RESEARCH INC

Federal contract award, Leidos, $219,752

Key CONT_AWD_75N91025F00022_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 360 days before this system saw it. One version on record.

Cite this row

On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_75N91025F00022_7529_75N91019D00024_7529
At the source https://www.usaspending.gov/award/CONT_AWD_75N91025F00022_7529_75N91019D00024_7529
Observed 2026-09-05, version 1, retrieved 2026-09-05T00:58:05Z
Content hash 0b806c5de4c8beeb3db2a6996328f9a33545a7df3fb687b4f962ccdc57289b5a

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

VersionAmountChangeOccurredPublishedRetrievedHow it arrivedContent hash
1
current
$219,752first versionSeptember 10, 2025September 10, 20252026-09-05T00:58:05Zhistorical sweep0b806c5de4c8

Archived copy

https://web.archive.org/web/20261019112821/https://www.usaspending.gov/award/CONT_AWD_75N91025F00022_7529_75N91019D00024_7529 captured by this system, October 19, 2026

What the amount is made of

One recorded action, so the amount is that single obligation and nothing about it is cumulative. Measured 2026-10-05, when USAspending reported a total obligation of $219,752.

Action dateModificationTypeObligatedDescription as recorded
September 10, 2025basenot on file+$219,752EVALUATION OF IVO COMPOUNDS IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS MODEL

Last refreshed November 4, 2026 at 2:31 PM UTC.